维德伯诺:一种以天然产品为灵感的化学工具,用于中枢神经系统的药物设计
Anna Egorova1, Eugene Zubkov2, Vadim Makarov1
1Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, 119071, Moscow, Russia.
European journal of medicinal chemistry
|October 16, 2024
概括
维德伯诺尔是一种以天然产品为灵感的分子,对治疗中枢神经系统疾病如阿尔茨海默氏症和多发性硬化症有前途. 尽管早期潜力很大,但它的发展被停止了,但它仍然是未来中枢神经系统药物发现的宝贵支架.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自然产品 (NP) 是中枢神经系统 (CNS) 活性剂的重要来源.
- 维德伯诺尔 (VIND) 是由埃伯纳米因-温卡米因类化合物衍生而来的,其生物活性已被研究.
- 在中枢神经系统疾病的临床前模型中,VIND表现出潜在的治疗效果.
研究的目的:
- 审查用于 vindeburnol 的合成策略.
- 为了全面讨论 vindeburnol 的药理作用.
- 探索用于中枢神经系统药物设计的芬德伯诺尔衍生品和类似物.
主要方法:
- 关于合成方法的文献综述 在 vindeburnol.
- 在动物模型和人体试验中编制和分析药理学研究.
- 检查结构变化及其对生物活动的影响.
主要成果:
- 介绍了Vindeburnol的合成途径.
- 讨论了体内模型 (多发性硬化症,阿尔茨海默病,抑郁症) 和有限的人体试验的药理学数据.
- 维德伯诺和其类似物显示出对中枢神经系统应用的巨大潜力.
结论:
- 尽管开发已停止,但Vindeburnol仍然为中枢神经系统药物设计提供了宝贵的见解.
- 它的支架作为开发下一代神经和精神疾病治疗方法的有希望的基础.
- 进一步研究温德伯诺衍生物可能会为中枢神经系统疾病提供新的治疗方法.
关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.类似于抑郁症的行为埃伯纳明-温卡明类类化合物多发性硬化症是多发性硬化症.药理学效应 药理学效应 是一种药理学效应.综合合成 综合合成铁氨酸氧化酶是一种氨酸氧化酶.葡萄酒可以燃烧.更多相关视频
相关概念视频
01:29Drug Delivery: Parenteral Route
438
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
438
01:28Structure-Activity Relationships and Drug Design
668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
01:26Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
01:25Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
01:26Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K